These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8987091)

  • 1. Application of the electrotopological state index to QSAR analysis of flavone derivatives as HIV-1 integrase inhibitors.
    Buolamwini JK; Raghavan K; Fesen MR; Pommier Y; Kohn KW; Weinstein JN
    Pharm Res; 1996 Dec; 13(12):1892-5. PubMed ID: 8987091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linear indices of the "molecular pseudograph's atom adjacency matrix": definition, significance-interpretation, and application to QSAR analysis of flavone derivatives as HIV-1 integrase inhibitors.
    Marrero-Ponce Y
    J Chem Inf Comput Sci; 2004; 44(6):2010-26. PubMed ID: 15554670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional quantitative structure-activity relationship (QSAR) of HIV integrase inhibitors: a comparative molecular field analysis (CoMFA) study.
    Raghavan K; Buolamwini JK; Fesen MR; Pommier Y; Kohn KW; Weinstein JN
    J Med Chem; 1995 Mar; 38(6):890-7. PubMed ID: 7699704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of CoMFA and CoMSIA 3D-QSAR and docking studies in optimization of mercaptobenzenesulfonamides as HIV-1 integrase inhibitors.
    Kuo CL; Assefa H; Kamath S; Brzozowski Z; Slawinski J; Saczewski F; Buolamwini JK; Neamati N
    J Med Chem; 2004 Jan; 47(2):385-99. PubMed ID: 14711310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR study of curcumine derivatives as HIV-1 integrase inhibitors.
    Gupta P; Sharma A; Garg P; Roy N
    Curr Comput Aided Drug Des; 2013 Mar; 9(1):141-50. PubMed ID: 23286784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.
    Buolamwini JK; Assefa H
    J Med Chem; 2002 Feb; 45(4):841-52. PubMed ID: 11831895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivariate QSAR study of 4,5-dihydroxypyrimidine carboxamides as HIV-1 integrase inhibitors.
    de Melo EB; Ferreira MM
    Eur J Med Chem; 2009 Sep; 44(9):3577-83. PubMed ID: 19327872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel HIV-1 integrase inhibitors using shape-based screening, QSAR, and docking approach.
    Gupta P; Garg P; Roy N
    Chem Biol Drug Des; 2012 May; 79(5):835-49. PubMed ID: 22233531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cluster analysis and three-dimensional QSAR studies of HIV-1 integrase inhibitors.
    Yuan H; Parrill A
    J Mol Graph Model; 2005 Jan; 23(4):317-28. PubMed ID: 15670952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring binding mode for styrylquinoline HIV-1 integrase inhibitors using comparative molecular field analysis and docking studies.
    Ma XH; Zhang XY; Tan JJ; Chen WZ; Wang CX
    Acta Pharmacol Sin; 2004 Jul; 25(7):950-8. PubMed ID: 15210071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse models for the prediction of HIV integrase inhibitory activity of substituted quinolone carboxylic acids.
    Gupta M; Madan AK
    Arch Pharm (Weinheim); 2012 Dec; 345(12):989-1000. PubMed ID: 22945879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors.
    Leonard JT; Roy K
    Eur J Med Chem; 2008 Jan; 43(1):81-92. PubMed ID: 17452064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational models on quantitative prediction of bioactivity of HIV-1 integrase 3' processing inhibitors.
    Kong Y; Xuan S; Yan A
    SAR QSAR Environ Res; 2014; 25(9):729-46. PubMed ID: 25121566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QSAR of HIV-1 integrase inhibitors by genetic function approximation method.
    Makhija MT; Kulkarni VM
    Bioorg Med Chem; 2002 May; 10(5):1483-97. PubMed ID: 11886811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CoMFA and CoMSIA 3D-QSAR studies on quionolone caroxylic acid derivatives inhibitors of HIV-1 integrase.
    Lu P; Wei X; Zhang R
    Eur J Med Chem; 2010 Aug; 45(8):3413-9. PubMed ID: 20488589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacophore modelling and atom-based 3D-QSAR studies on N-methyl pyrimidones as HIV-1 integrase inhibitors.
    Reddy KK; Singh SK; Dessalew N; Tripathi SK; Selvaraj C
    J Enzyme Inhib Med Chem; 2012 Jun; 27(3):339-47. PubMed ID: 21699459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D-QSAR studies of quinoline ring derivatives as HIV-1 integrase inhibitors.
    Sun XH; Guan JQ; Tan JJ; Liu C; Wang CX
    SAR QSAR Environ Res; 2012 Oct; 23(7-8):683-703. PubMed ID: 22991976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of N-methylpyrimidone derivatives as HIV-1 integrase inhibitors.
    Wang Y; Rong J; Zhang B; Hu L; Wang X; Zeng C
    Bioorg Med Chem; 2015 Feb; 23(4):735-41. PubMed ID: 25618597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docking-based CoMFA and CoMSIA study of azaindole carboxylic acid derivatives as promising HIV-1 integrase inhibitors.
    Yu S; Wang P; Li Y; Liu Y; Zhao G
    SAR QSAR Environ Res; 2013 Oct; 24(10):819-39. PubMed ID: 23988186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular electrostatic potentials as input for the alignment of HIV-1 integrase inhibitors in 3D QSAR.
    Makhija MT; Kulkarni VM
    J Comput Aided Mol Des; 2001 Nov; 15(11):961-78. PubMed ID: 11989625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.